These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 14516920)

  • 1. An animal model of neonatal cytomegalovirus infection.
    Bravo FJ; Bourne N; Schleiss MR; Bernstein DI
    Antiviral Res; 2003 Sep; 60(1):41-9. PubMed ID: 14516920
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of maternal treatment with cyclic HPMPC in the guinea pig model of congenital cytomegalovirus infection.
    Bravo FJ; Cardin RD; Bernstein DI
    J Infect Dis; 2006 Feb; 193(4):591-7. PubMed ID: 16425139
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activity of (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine (HPMPC) against guinea pig cytomegalovirus infection in cultured cells and in guinea pigs.
    Li SB; Yang ZH; Feng JS; Fong CK; Lucia HL; Hsiung GD
    Antiviral Res; 1990 May; 13(5):237-52. PubMed ID: 2168690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclic HPMPC is safe and effective against systemic guinea pig cytomegalovirus infection in immune compromised animals.
    Bourne N; Bravo FJ; Bernstein DI
    Antiviral Res; 2000 Aug; 47(2):103-9. PubMed ID: 10996398
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute murine cytomegalovirus infection: a model for determining antiviral activity against CMV induced hepatitis.
    Bolger G; Lapeyre N; Rhéaume M; Kibler P; Bousquet C; Garneau M; Cordingley M
    Antiviral Res; 1999 Dec; 44(3):155-65. PubMed ID: 10651067
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative-competitive PCR monitoring of viral load following experimental guinea pig cytomegalovirus infection.
    Schleiss MR; Bourne N; Bravo FJ; Jensen NJ; Bernstein DI
    J Virol Methods; 2003 Mar; 108(1):103-10. PubMed ID: 12565160
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New inhibitors of cytomegalovirus replication: in vitro evaluation, mechanism of action, and in vivo activity.
    Neyts J; De Clercq E
    Verh K Acad Geneeskd Belg; 1994; 56(6):561-92. PubMed ID: 7892749
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of 2'-nor-cyclic GMP against guinea pig cytomegalovirus infection.
    Yang ZH; Lucia HL; Tolman RL; Colonno RJ; Hsiung GD
    Antimicrob Agents Chemother; 1989 Sep; 33(9):1563-8. PubMed ID: 2554800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined treatment with 2'-nor-cGMP and ganciclovir against cytomegalovirus infection in a guinea pig model.
    Feng JS; Crouch JY; Tolman RL; Lucia HL; Hsiung GD
    Antiviral Res; 1992 Sep; 19(3):193-206. PubMed ID: 1332604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effective treatment of experimental cytomegalovirus-induced encephalo-meningitis in immunocompromised rats with HPMPC.
    Kloover JS; Vanagt WY; Stals FS; Bruggeman CA
    Antiviral Res; 1997 Jul; 35(2):105-12. PubMed ID: 9217247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiviral effect of 9-(1,3-dihydroxy-2-propoxymethyl)guanine against cytomegalovirus infection in a guinea pig model.
    Fong CK; Cohen SD; McCormick S; Hsiung GD
    Antiviral Res; 1987 Jan; 7(1):11-23. PubMed ID: 3026243
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral treatment of murine cytomegalovirus infections with ether lipid esters of cidofovir.
    Kern ER; Collins DJ; Wan WB; Beadle JR; Hostetler KY; Quenelle DC
    Antimicrob Agents Chemother; 2004 Sep; 48(9):3516-22. PubMed ID: 15328119
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral hexadecyloxypropyl-cidofovir therapy in pregnant guinea pigs improves outcome in the congenital model of cytomegalovirus infection.
    Bravo FJ; Bernstein DI; Beadle JR; Hostetler KY; Cardin RD
    Antimicrob Agents Chemother; 2011 Jan; 55(1):35-41. PubMed ID: 21078944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rat cytomegalovirus-induced pneumonitis after allogeneic bone marrow transplantation: effective treatment with (S)-1-(3-hydroxy-2-phosphonyl-methoxypropyl)cytosine.
    Stals FS; Zeytinoglu A; Havenith M; de Clercq E; Bruggeman CA
    Antimicrob Agents Chemother; 1993 Feb; 37(2):218-23. PubMed ID: 8383939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phosphonylmethoxyalkyl purine and pyrimidine derivatives for treatment of opportunistic cytomegalovirus and herpes simplex virus infections in murine AIDS.
    De Castro LM; Kern ER; De Clercq E; Ghaffar A; Mayer EP; Vogt PE; Gangemi JD
    Antiviral Res; 1991 Jul; 16(1):101-14. PubMed ID: 1663726
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The non-nucleoside antiviral, BAY 38-4766, protects against cytomegalovirus (CMV) disease and mortality in immunocompromised guinea pigs.
    Schleiss MR; Bernstein DI; McVoy MA; Stroup G; Bravo F; Creasy B; McGregor A; Henninger K; Hallenberger S
    Antiviral Res; 2005 Jan; 65(1):35-43. PubMed ID: 15652969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Value of animal models to evaluate agents with potential activity against human cytomegalovirus.
    Kern ER
    Transplant Proc; 1991 Jun; 23(3 Suppl 3):152-5, discussion 155. PubMed ID: 1648821
    [No Abstract]   [Full Text] [Related]  

  • 18. Cyclic cidofovir (cHPMPC) prevents congenital cytomegalovirus infection in a guinea pig model.
    Schleiss MR; Anderson JL; McGregor A
    Virol J; 2006 Mar; 3():9. PubMed ID: 16509982
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictive efficacy of SCID-hu mouse models for treatment of human cytomegalovirus infections.
    Kern ER; Rybak RJ; Hartline CB; Bidanset DJ
    Antivir Chem Chemother; 2001; 12 Suppl 1():149-56. PubMed ID: 11594682
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of acyclovir and phosphonoformate on cytomegalovirus infection in guinea pigs.
    Lucia HL; Griffith BP; Hsiung GD
    Intervirology; 1984; 21(3):141-9. PubMed ID: 6327560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.